Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study

Risk Factors for Tigecycline-Associated Hypofibrinogenemia

(2021) Jia Liu et al.   Therapeutics and Clinical Risk Management

Comparison of Bleeding Risk Between Colistin–Tigecycline and Colistin–Carbapenem Treatment Regimens: A Retrospective Cohort Study

(2021) Yu-Ting Huang et al.   Infection and Drug Resistance

Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis

(2021) Benedikt Treml et al.   Journal of Clinical Medicine

Tigecycline versus INR increase; more than expected?

(2020) Damla Akdağ et al.   Expert Opinion On Drug Safety

Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients

(2020) Juan Hu et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit

(2020) Stephen P. Bergin et al.   CHEST

Tigecycline-associated hypofibrinogenemia in a real-world setting

(2020) David Campany-Herrero et al.   International Journal of Clinical Pharmacy

Risk factors for tigecycline‐induced hypofibrinogenaemia

(2020) Qian Zhang et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Population Pharmacokinetics and Exposure‐Response Analysis of Tigecycline in Patients with Hospital‐Acquired Pneumonia

(2020) Yangang Zhou et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial

(2019) Mukul Sharma et al.   CIRCULATION

A Retrospective Analysis of the Effect of Tigecycline on Coagulation Function

(2019) Bing Leng et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

(2019) Yangang Zhou et al.   BMC Pharmacology & Toxicology

Low preoperative fibrinogen level is risk factor for neurological complications in acute aortic dissection

(2018) Xinliang Guan et al.   MEDICINE

In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China

(2018) Tao Li et al.   Journal of Thoracic Disease

Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations

(2017) H. Toinét Cronjé et al.   PLoS One

Coagulation parameters and major bleeding in critically ill patients with cirrhosis

(2016) Andreas Drolz et al.   HEPATOLOGY

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE

(2015) Peter Brønnum Nielsen et al.   CIRCULATION

Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder

(2015) Nikolaos Sabanis et al.   Infectious Diseases

Tetracycline antibiotics and resistance mechanisms

(2014) Fabian Nguyen et al.   BIOLOGICAL CHEMISTRY

Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis

(2014) Giacomo Rossitto et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

(2013) Yongjun Wang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fibrinogen and Hemostasis

(2011) Jerrold H. Levy et al.   ANESTHESIA AND ANALGESIA

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

(2011) M. B. Leon et al.   EUROPEAN HEART JOURNAL

Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline

(2010) Herwig Pieringer et al.   ANNALS OF HEMATOLOGY

Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines

(2009) Ranime Saliba et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

(2008) Cristina Tanaseanu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Evaluation of a Potential Tigecycline-Warfarin Drug Interac

(2008) James J Zimmerman et al.   PHARMACOTHERAPY